These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23334071)

  • 21. M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine.
    Witkin JM; Overshiner C; Li X; Catlow JT; Wishart GN; Schober DA; Heinz BA; Nikolayev A; Tolstikov VV; Anderson WH; Higgs RE; Kuo MS; Felder CC
    J Pharmacol Exp Ther; 2014 Nov; 351(2):448-56. PubMed ID: 25187432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response.
    Dong J; Zhou Q; Wei Z; Yan S; Sun F; Cai X
    J Affect Disord; 2018 Feb; 227():633-642. PubMed ID: 29174736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials.
    Moćko P; Śladowska K; Kawalec P; Babii Y; Pilc A
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
    Sidor MM; Macqueen GM
    J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
    Gerhard DM; Wohleb ES; Duman RS
    Drug Discov Today; 2016 Mar; 21(3):454-64. PubMed ID: 26854424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder.
    Chen JCC; Sumner RL; Naga VK; Hoeh N; Ayeni HA; Singh V; Wilson A; Campbell D; Sundram F; Muthukumaraswamy SD
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35980261
    [No Abstract]   [Full Text] [Related]  

  • 28. Baseline mood-state measures as predictors of antidepressant response to scopolamine.
    Furey ML; Nugent AC; Speer AM; Luckenbaugh DA; Hoffman EM; Frankel E; Drevets WC; Zarate CA
    Psychiatry Res; 2012 Mar; 196(1):62-7. PubMed ID: 22349648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD; Doraiswamy PM
    Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors.
    Navarria A; Wohleb ES; Voleti B; Ota KT; Dutheil S; Lepack AE; Dwyer JM; Fuchikami M; Becker A; Drago F; Duman RS
    Neurobiol Dis; 2015 Oct; 82():254-261. PubMed ID: 26102021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice.
    Petryshen TL; Lewis MC; Dennehy KA; Garza JC; Fava M
    Neurosci Lett; 2016 May; 620():70-3. PubMed ID: 27033002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.
    Addy NA; Nunes EJ; Wickham RJ
    Behav Brain Res; 2015 Jul; 288():54-62. PubMed ID: 25865152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis.
    Wijkstra J; Lijmer J; Balk FJ; Geddes JR; Nolen WA
    Br J Psychiatry; 2006 May; 188():410-5. PubMed ID: 16648526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant treatment of depression: a metaanalysis.
    Joffe R; Sokolov S; Streiner D
    Can J Psychiatry; 1996 Dec; 41(10):613-6. PubMed ID: 8978938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy.
    Bschor T; Baethge C
    Acta Psychiatr Scand; 2010 Mar; 121(3):174-9. PubMed ID: 19703121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting.
    Pergolizzi JV; Philip BK; Leslie JB; Taylor R; Raffa RB
    J Clin Anesth; 2012 Jun; 24(4):334-45. PubMed ID: 22608591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.